A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD1.14
- USD1.15
- USD1.11
- USD4.40
- -9.50%
- --
- 16.88k
- 23.85k
- 38M
- 0.85
- -68.00%
Stock News
4 hours ago
These are America's 10 strongest state economies best prepared for a recession
CNBC
5 hours ago
A 38-year-old started his hummus business with a $450 blender. This year, it's set to bring in $50 million
CNBC
5 hours ago
How to handle an inheritance and build wealth — even when you think you’re ready
MarketWatch
5 hours ago
The Saturday Spread: Leveraging Applied Game Theory to Find Probabilistically Attractive Trades
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
